Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Toronto

$30,000.00

Defining factors that control human innate lymphoid cell development and function

FY 2021-22

Summary
Innate lymphoid cells (ILCs) are a family of lymphocytes with pivotal roles in orchestrating immune responses and regulating tissue homeostasis. While inflammatory ILCs serve important functions in host defence and anti-tumour immunity, we and others have identified regulatory ILC populations that inhibit immune responses or recruit other suppressive cells. Animal studies have provided a roadmap of transcriptional networks that control ILC identity and function, yet studies of human ILCs are relatively scarce. Studies addressing human ILCs development, regulation and plasticity are greatly needed to understand pathways that direct human ILC development and determine how microenvironment factors influence their function. This research is centred on delineating molecular mechanisms that control human ILC development and function, with a particular focus on regulatory ILCs. Aim 1: Define key pathways that drive ILCreg development and function. We aim to identify pathways and transcription factors involved in regulatory ILC development and function using advanced genomics platforms. Induced regulatory ILCs will be contrasted with canonical ILCs using established methods to isolate and expand in vivo-derived human ILCs. Relevance of pathways and molecules associated with immunosuppressive functions and tissue repair activity will then be explored. Aim 2: Examine the plasticity of induced regulatory ILCs and canonical human ILC subsets. How different cytokines and microenvironment factors influence circulating and tissue-resident human ILCs from healthy individuals has not been determined. We aim to determine the stability or plasticity of human ILCs in blood and healthy human tissues (kidney, pancreas, spleen) by isolating ILCs, exposing them to various cytokines and profiling them at the epigenetic, transcriptional and protein level using advanced genomic and immunological platforms. Induced regulatory ILCs will also be examined for their ability to maintain their phenotype or convert to other ILC subsets with cytokine stimulations.  Aim 3: Assess the role of transcription factors in ILC development and function. A key question is whether there is a lineage defining transcription factor for regulatory ILCs. RNAseq analysis of human in vivo-derived regulatory ILCs identified transcription factors of interest, and Aim 1 aims to identify transcription factors that distinguish induced regulatory ILCs. Here, we will explore the role of several transcription factors in human ILC development and function using a lentiviral gene transfer system. Gene expression networks and ILC functions downstream of these transcription factors will be examined, the influence of regulatory ILC-associated transcription factors on ILC development and function determined. Novelty: Our studies of ILCregs and human ILCs from healthy individuals will expand our understanding of molecular pathways that control human ILC development and function.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2021-03672
Name nom
Crome, Sarah
Department département
TGHRI, Experimental Therapeutics, Immunity and Infection Group
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Installment
inst:1
Partie
1
Nb partie
5
Application title
Defining factors that control human innate lymphoid cell development and function
Keyword
NSERC
Application summary
Innate lymphoid cells (ILCs) are a family of lymphocytes with pivotal roles in orchestrating immune responses and regulating tissue homeostasis. While inflammatory ILCs serve important functions in host defence and anti-tumour immunity, we and others have identified regulatory ILC populations that inhibit immune responses or recruit other suppressive cells. Animal studies have provided a roadmap of transcriptional networks that control ILC identity and function, yet studies of human ILCs are relatively scarce. Studies addressing human ILCs development, regulation and plasticity are greatly needed to understand pathways that direct human ILC development and determine how microenvironment factors influence their function. This research is centred on delineating molecular mechanisms that control human ILC development and function, with a particular focus on regulatory ILCs. Aim 1: Define key pathways that drive ILCreg development and function. We aim to identify pathways and transcription factors involved in regulatory ILC development and function using advanced genomics platforms. Induced regulatory ILCs will be contrasted with canonical ILCs using established methods to isolate and expand in vivo-derived human ILCs. Relevance of pathways and molecules associated with immunosuppressive functions and tissue repair activity will then be explored. Aim 2: Examine the plasticity of induced regulatory ILCs and canonical human ILC subsets. How different cytokines and microenvironment factors influence circulating and tissue-resident human ILCs from healthy individuals has not been determined. We aim to determine the stability or plasticity of human ILCs in blood and healthy human tissues (kidney, pancreas, spleen) by isolating ILCs, exposing them to various cytokines and profiling them at the epigenetic, transcriptional and protein level using advanced genomic and immunological platforms. Induced regulatory ILCs will also be examined for their ability to maintain their phenotype or convert to other ILC subsets with cytokine stimulations.  Aim 3: Assess the role of transcription factors in ILC development and function. A key question is whether there is a lineage defining transcription factor for regulatory ILCs. RNAseq analysis of human in vivo-derived regulatory ILCs identified transcription factors of interest, and Aim 1 aims to identify transcription factors that distinguish induced regulatory ILCs. Here, we will explore the role of several transcription factors in human ILC development and function using a lentiviral gene transfer system. Gene expression networks and ILC functions downstream of these transcription factors will be examined, the influence of regulatory ILC-associated transcription factors on ILC development and function determined. Novelty: Our studies of ILCregs and human ILCs from healthy individuals will expand our understanding of molecular pathways that control human ILC development and function.